NET PROFIT (x1000 SEK)
EMPLOYEES
Recipharm Stockholm AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
14
|
3,171
|
5,729 |
Earnings before taxes |
505
|
-858
|
15,856 |
EBITDA |
-366
|
256
|
18,966 |
Total assets |
24,022
|
23,670
|
108,264 |
Current assets |
24,022
|
22,976
|
106,762 |
Current liabilities |
35
|
1,952
|
83,989 |
Equity capital |
23,987
|
21,262
|
21,668 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
0
![]() |
0
|
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
99.9%
|
89.8%
|
20.0% |
Turnover per employee | 0 | ||
Profit as a percentage of turnover | |||
Return on assets (ROA) |
2.2%
|
9.8%
|
19.9% |
Current ratio |
68634.3%
|
1177.0%
|
127.1% |
Return on equity (ROE) |
2.1%
|
-4.0%
|
73.2% |
Change turnover |
0
![]() |
0
|
-219,508 |
Change turnover % | -100% | ||
Chg. No. of employees |
0
|
-15
|
-119 |
Chg. No. of employees % |
-100%
|
-89% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.